Patient info Search Menu

GOOD-NITE Capsules – Summary of Product Characteristics (SmPC) for healthcare professionals

Updated:

Summary of Product Characteristics (SmPC) - Good-nite capsules

1 NAME OF THE MEDICINAL PRODUCT

GOOD-NITE Capsules

2 QUALITATIVE AND QUANTITATIVE COMPOSITION

Each capsule contains 400mg of Valerian root. (Valeriana officinalis L.)

For list of excipients see section 6.1.

3 PHARMACEUTICAL FORM

Hard capsules.

Clear size 0 hard capsules.

4 CLINICAL PARTICULARS

4.1 Therapeutic indications

GOOD-NITE is a traditional herbal medicinal product used to aid sleep, based on traditional use only.

4.2 Posology and method of administration

For oral short term use only.

Adults and the elderly:

To aid sleep, take one capsule 30 minutes before bedtime with an earlier dose during the evening if necessary.

As treatment effects may not be apparent immediately, GOOD-NITE should be taken 2-4 weeks continuously.

Duration of use:-

If symptoms persist, worsen or do not improve after 4 weeks during the use of GOOD-NITE a doctor or a qualified healthcare care practitioner should be consulted.

Not recommended for children or adolescents under 18 years.

(See Section 4.4. Special warnings and precautions for use).

4.3 Contraindications

Hypersensitivity to Valerian or to any of the excipients.

4.4 Special warnings and precautions for use

Do not exceed the stated dose.

If symptoms worsen, or do not improve after 4 weeks of taking GOOD-NITE a doctor or a qualified healthcare care practitioner should be consulted.

The use of this product is not recommended in children and adolescents below the age of 18 years because data are not sufficient and medical advice should be sought.

4.5 Interaction with other medicinal products and other forms of interaction

Only limited data on pharmacological interactions with other medicinal products are available.

Clinically relevant interactions with drugs metabolised by the CYP 2D6, CYP 3A4/5, CYP 1A2 or CYP 2E1 pathway has not been observed. Additive effects with hypnotics and other sedatives cannot be excluded and therefore co-medication is not recommended as a general precaution.

The effect of Valerian may be potentiated by alcohol. Excessive concomitant consumption of alcohol should therefore be avoided.

4.6 Fertility, pregnancy and lactation

The safety of GOOD-NITE during pregnancy and lactation has not been established. Due to the lack of data, use during pregnancy and lactation is not recommended. Studies on the effect on fertility have not been performed.

4.7 Effects on ability to drive and use machines

GOOD-NITE may cause dizziness and impair ability to drive and use machines. Patients who are affected should not drive or operate machinery.

4.8 Undesirable effects

Gastrointestinal symptoms, such as nausea, vomiting, abdominal cramps and diarrhoea may occur. Dizziness, headaches and nightmares or vivid dreams may also occur. The frequency is not known.

If other adverse reactions not mentioned above occur, a doctor or qualified health care practitioner should be consulted.

4.9 Overdose

If symptoms arise, treatment should be supportive.

Valerian root at a dose of approximately 20g (equivalent to 50 GOOD-NITE capsules) caused benign symptoms (fatigue, abdominal cramp, chest tightness, light headedness, hand tremor and mydriasis), which disappeared within 24 hours. After intake of very high doses of Valerian root over several years (daily consumption corresponding to approximately 30g of the drug) withdrawal symptoms (delirium) have been reported.

5 PHARMACOLOGICAL PROPERTIES

5.1 Pharmacodynamic properties

Not required as per article 16c (1) (a) (iii) of Directive 2001/83/EC as amended.

5.2 Pharmacokinetic properties

Not required as per article 16c (1) (a) (iii) of Directive 2001/83/EC as amended.

5.3 Preclinical safety data

Extracts with ethanol and the essential oil of Valerian root have shown low toxicity in rodents during acute tests and from repeated dose toxicity over periods of 4-8 weeks. Test on reproductive toxicity, genotoxicity and carcinogenicity have not been performed.

6 PHARMACEUTICAL PARTICULARS

6.1 List of excipients

Hypromellose (capsule shell)

6.2 Incompatibilities

Not applicable

6.3 Shelf life

3 years

6.4 Special precautions for storage

Store below 25°C. Store in the original package.

6.5 Nature and contents of container

Duma 110ml HDPE plastic container and tamper evident threaded Duma cap. GOOD-NITE pack contains 50 Capsules.

6.6 Special precautions for disposal

There are no special precautions for disposal of GOOD-NITE capsules.

7 MARKETING AUTHORISATION HOLDER

Bio-Health Limited

Culpeper Close

Medway City Estate

Rochester

Kent

ME2 4HU

8 MARKETING AUTHORISATION NUMBER(S)

THR 15817/0011

9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE

AUTHORISATION

12/02/2019

10 DATE OF REVISION OF THE TEXT

27/10/2023

About this document

Source: MHRA - Medicines and Healthcare products Regulatory Agency (products.mhra.gov.uk) · Marketing authorisation: THR158170011

Last revision stated in the text: 27 October 2023 · MHRA data as of 13 October 2026

What the sections and the side effect frequencies mean: How to read a patient leaflet

Found a mistake? Tell us on the contact page.

The information on this site does not replace the advice of a doctor or pharmacist.

Facts about Good-nite capsules

What these facts mean

Pharmaceutical form? Clear size 0 hard capsules.
Excipients? Hypromellose (capsule shell)
Shelf life? 3 years
Storage Store below 25°C. Store in the original package.
Marketing authorisation? THR 15817/0011 (first authorised 12 February 2019)
Marketing authorisation holder? Bio-Health Limited

Sources: the MHRA product information (products.mhra.gov.uk). Contains public sector information licensed under the Open Government Licence v3.0.